US FDA reverses course, will review Moderna's revised flu vaccine application
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The US FDA has reversed its previous stance and will review Moderna's flu vaccine application. The vaccine in question is an mRNA-based flu vaccine. The details of the reversal and the application's contents are not specified, but multiple outlets confirm that the FDA will proceed with the review.
Full coverage
1
Reuters·Feb 182
CNBC·Feb 183
The Guardian·Feb 184
NPR·Feb 185
CNN·Feb 186
CIDRAP·Feb 187
The American Journal of Managed Care® (AJMC®)·Feb 188
The New York Times·Feb 18